Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.47 |
| ▸ | CCR5 | P51681 | 1/20 | 0.47 |
| ▸ | CCR8 | P51685 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | METAP2 | P50579 | 1/20 | 0.36 |
| ▸ | KDM1A | O60341 | 2/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.36 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.35 |
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
| ▸ | ABL1 | P00519 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6130784 | 0.82 | CCR1 (0.55) | CCR1CCR5CCR8CYP2A6METAP2 | |
| SCHEMBL12750061 | 0.81 | CCR1 (0.51) | CCR1CCR5CCR8KDM1ATGFBR1 | |
| SCHEMBL12750066 | 0.81 | KDM4E (0.35) | TRPA1TRPV4MPLKDM4ESYK | |
| SCHEMBL10014747 | 0.81 | CCR1 (0.53) | CCR1CCR5CCR8CYP2A6METAP2 | |
| SCHEMBL503501 | 0.78 | CCR1 (0.50) | CCR1CCR5CCR8CYP2A6METAP2 | |
| SCHEMBL12319859 | 0.78 | CCR1 (0.46) | CCR1CCR5CCR8PTGS2CYP2A6 | |
| SCHEMBL4819036 | 0.77 | MPL (0.49) | CCR1CCR5CCR8PTGS2KDM1A | |
| SCHEMBL3445756 | 0.76 | KDM4E (0.42) | CCR1CCR5CCR8MPLKDM4E | |
| SCHEMBL12750057 | 0.75 | CCR1 (0.46) | CCR1CCR5CCR8CYP2A6METAP2 | |
| SCHEMBL12828420 | 0.75 | CCR1 (0.46) | CCR1CCR5CCR8CYP2A6METAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9722191-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-08-01 | — | — | US | disclosed |
| US-20160043330-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-02-11 | — | — | US | disclosed |
| US-20120025177-A1 | Phosphorescent light-emitting iridium complex containing pyridyltriazole ligand | SOLVAY SA (BE) | 2012-02-02 | — | — | US | disclosed |
| US-20120025177-A1 | Phosphorescent light-emitting iridium complex containing pyridyltriazole ligand | SOLVAY SA (BE) | 2012-02-02 | — | — | US | disclosed |
| EP-2393820-A1 | PHOSPHORESCENT LIGHT-EMITTING IRIDIUM COMPLEX CONTAINING PYRIDYLTRIAZOLE LIGAND | Solvay SA (BE) | 2011-12-14 | — | — | EP | disclosed |
| US-7915414-B2 | Blue-emitting organometallic complexes and their application | Chi, Yun (TW) | 2011-03-29 | — | — | US | disclosed |
| WO-2010093176-A2 | IRIDIUM COMPLEX AND ORGANIC LIGHT-EMITTING DIODES | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2010-08-19 | — | — | WO | disclosed |
| WO-2010090362-A1 | PHOSPHORESCENT LIGHT-EMITTING IRIDIUM COMPLEX CONTAINING PYRIDYLTRIAZOLE LIGAND | PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2010-08-12 | — | — | WO | disclosed |
| US-20080125591-A1 | Blue-Emitting Organometallic Complexes And Their Application | Chi, Yun (TW) | 2008-05-29 | — | — | US | disclosed |
| US-20080125591-A1 | Blue-Emitting Organometallic Complexes And Their Application | Chi, Yun (TW) | 2008-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080125591-A1 | Blue-Emitting Organometallic Complexes And Their Application | CYBA, IK, CRY1 | CCR1 4516/4885CCR5 3708/4885CCR8 4712/4885 |
| US-20120025177-A1 | Phosphorescent light-emitting iridium complex containing pyridyltriazole ligand | PPIP5K2, HPRT1, PHPT1 | CCR1 3890/4885CCR5 3260/4885CCR8 3813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.